- Previous Close
84.45 - Open
86.00 - Bid 86.40 x --
- Ask 86.80 x --
- Day's Range
85.65 - 86.60 - 52 Week Range
75.10 - 93.00 - Volume
23,522 - Avg. Volume
0 - Market Cap (intraday)
547.97M - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
721.67 - EPS (TTM)
0.12 - Earnings Date --
- Forward Dividend & Yield 0.06 (6.99%)
- Ex-Dividend Date Feb 13, 2025
- 1y Target Est
--
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes. The Group's portfolio at 31 December 2023 comprised 98 assets let to 32 tenants with a total value of £911.1 million. The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
www.targethealthcarereit.co.uk--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: THRLL.XC
View MorePerformance Overview: THRLL.XC
Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: THRLL.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: THRLL.XC
View MoreValuation Measures
Market Cap
529.06M
Enterprise Value
--
Trailing P/E
7.15
Forward P/E
13.59
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.65
Price/Book (mrq)
0.76
Enterprise Value/Revenue
9.86
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
104.99%
Return on Assets (ttm)
3.86%
Return on Equity (ttm)
10.87%
Revenue (ttm)
69.55M
Net Income Avi to Common (ttm)
73.02M
Diluted EPS (ttm)
0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
38.88M
Total Debt/Equity (mrq)
34.92%
Levered Free Cash Flow (ttm)
43.08M